From sickness to prevention: the case for population health management

October 3, 2025
Business Services, Market Access, Market Access Consultancy Corporate, Gateway to Local Adoption, NHS, Pharmacy, Population Health Management, Visions4Health, pharmacy

In the third of the Gateway to Local Adoption series, Visions4Health caught up with James Scott, Digital and Informatics Specialist …

Micrima announces upcoming launch of new UK breast cancer assessment

October 3, 2025
Research and Development Micrima, breast cancer, oncology

Breast cancer remains one of the leading health threats to women over 35 in the UK Micrima, a healthcare technology …

Latham & Watkins appoints Lydia Torne as life sciences and IP partner

October 3, 2025
Latham & Watkins, intellectual property

Appointment brings specialist healthcare IP commercialisation expertise to the firm Latham & Watkins has appointed Lydia Torne as a partner …

Veranova appoints Joe Torres-Ocasio as senior vice president and chief operating officer

October 2, 2025
Veranova, antibody-drug conjugates, appointment

Appointment follows significant investment into US manufacturing footprint Active pharmaceutical ingredient (API) manufacturer Veranova has appointed Joe Torres-Ocasio as senior …

Pierre Fabre partners with Know Your Lemons Foundation for breast cancer awareness

October 2, 2025
Medical Communications Education, Pierre Fabre, breast cancer

The campaign focuses on early detection and education Pierre Fabre Laboratories has announced a partnership with the Know Your Lemons …

partnership

Nanoform partners with A&LS Pharma

October 2, 2025
Research and Development A&LS Pharma, Nanoform

Distribution agreement will make Nanoformโ€™s products available in South Korea Nanoform Finland has entered into a distribution agreement with Ageing …

Five Facts about Breast Cancer

October 2, 2025
Medical Communications Breast Cancer Awareness Month, Five Facts, Oncology, breast cancer

1 There are striking inequities in breast cancer burden regarding the Human Development Index (HDI), the United Nationโ€™s measure of …

Sanofi and Regeneronโ€™s Dupixent receives CHMP recommendation for chronic spontaneous urticaria

September 26, 2025
Research and Development Dupixent, Regeneron, Sanofi, urticaria

Sanofi and Regeneron have received a positive opinion from the European Medicines Agencyโ€™s (EMA) Committee for Medicinal Products for Human …

hsm_mobile_clinical_trial_istock-872676342

CSL Behring’s angioedema treatments receives NICE recommendation

September 26, 2025
Regulatory Affairs, Research and Development Andembry, CSL Behring, hereditary angioedema

The National Institute for Health and Care Excellence (NICE) has issued final draft guidance recommending CSL Behringโ€™s ANDEMBRY (garadacimab) for …

drug-trials

Gilead Foundation awards $6.5m in grants to support STEM education

September 26, 2025
Research and Development Funding and Investment, Gilead Sciences, stem

Gilead Sciences has committed over $6.5m in grant funding towards improving science, technology, engineering and maths (STEM) education, the company …

Lilly opens fourth US Gateway Labs site

September 26, 2025
Research and Development Eli Lilly, Local Investment, biotech, life sciences

Eli Lilly has opened its newest Lilly Gateway Labs (LGL) site in San Diego, California, expanding its network of shared …

partnership

Arkivum and PHARMASEAL partner on trial management platform

September 26, 2025
Research and Development Arkivum, PHARMASEAL, Trial Management

Arkivum, a digital archiving and preservation solutions provider, has entered into a collaborative agreement with PHARMASEAL, a software company specialising …

Combination treatments: Takedaโ€™s Implementation Framework and the broader landscape

September 23, 2025
Research and Development HIV/AIDS, Hepatology, NHS, NICE, Oncology, Takeda, combination therapy, oncology

Pharmafile talks to Emma Roffe, Oncology Country Head (UK & Ireland) about the combination treatment landscape and the impact of …

drug-trials

LGC Group opens $100M Organic Chemistry Synthesis Centre of Excellence

September 19, 2025
Medical Communications, Research and Development LGC Group, biotech, life sciences, pharma

LGC Group, a life sciences company, has opened its new Organic Chemistry Synthesis Centre of Excellence in Ontario, Canada after …

Lilly secures conditional MHRA approval for new blood cancer treatment

Crown Bioscience opens new US model development centre

September 19, 2025
Medical Communications, Research and Development CRO, biotech, crown bioscience, life sciences

Crown Bioscience, a US global contract research organisation (CRO) that is part of JSR Life Sciences and Japan-based JSR Corporation, …

UCB announces first-in-patient trial success for galvokimig in atopic dermatitis

September 18, 2025
Medical Communications, Research and Development Dermatology, UCB, atopic dermatitis, clinical trial

UCB has reported positive early clinical trial results for galvokimig, an investigational therapy for adults with moderate-to-severe atopic dermatitis (AD). …

mobile apps

electronRx to launch pDx app for remote monitoring of chronic respiratory disease

September 18, 2025
Research and Development Asthma & COPD, Devices, devices, electronRx, pDx, respiratory diseases (CRDs)

Digital medicine company electronRx, based in Cambridge, UK, has announced the upcoming launch of pDx, a mobile app designed to …

ProteoNic Biosciences launches platform to enhance cell line productivity

September 17, 2025
Research and Development Devices, ProteoNic Biosciences, cell line productivity, gene therapy

ProteoNic Biosciences, a biotechย company headquartered in Leiden, Germany has unveiled its latest technology platform, the 2G UNic transposon system, developed …

The Gateway to Local Adoption Series

Latest content